Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D So

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Bulletin of the World Health Organization|January 11, 2005
A fair deal for the future: flexibilities under TRIPSAnthony D So
Med (New York, N.Y.)|March 24, 2021
Achieving path-dependent equity for global COVID-19 vaccine allocationAnthony D So, Joshua Woo
BMJ (Clinical Research Ed.)|December 16, 2020
Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysisAnthony D So, Joshua Woo
Infectious Diseases of Poverty|July 16, 2013
Technology innovation for infectious diseases in the developing worldAnthony D So, Quentin Ruiz-Esparza
Upsala Journal of Medical Sciences|March 21, 2014
New business models for antibiotic innovationAnthony D So, Tejen A Shah
Infectious Diseases of Poverty|July 21, 2025
Mass drug administration trials of azithromycin: an analysis to inform future research and guidelinesAlex C Kong, Anthony D So
Health Affairs Scholar|May 21, 2024
Enabling product development partnerships to bring forward the next generation of health technologiesAnthony D So, Joshua Woo, Matthias Helble
BMJ (Clinical Research Ed.)|May 21, 2010
Tackling antibiotic resistanceAnthony D So, Neha Gupta, Otto Cars
BMJ (Clinical Research Ed.)|April 12, 2012
3Rs for innovating novel antibiotics: sharing resources, risks, and rewardsAnthony D So, Quentin Ruiz-Esparza, Neha Gupta, et al.
Infectious Diseases of Poverty|September 16, 2022
Ethical challenges in mass drug administration for reducing childhood mortality: a qualitative studyAhmed Alasmar, Alex C Kong, Anthony D So, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Bulletin of the World Health Organization|January 11, 2005
A fair deal for the future: flexibilities under TRIPSAnthony D So
Med (New York, N.Y.)|March 24, 2021
Achieving path-dependent equity for global COVID-19 vaccine allocationAnthony D So, Joshua Woo
BMJ (Clinical Research Ed.)|December 16, 2020
Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysisAnthony D So, Joshua Woo
Infectious Diseases of Poverty|July 16, 2013
Technology innovation for infectious diseases in the developing worldAnthony D So, Quentin Ruiz-Esparza
Upsala Journal of Medical Sciences|March 21, 2014
New business models for antibiotic innovationAnthony D So, Tejen A Shah
Infectious Diseases of Poverty|July 21, 2025
Mass drug administration trials of azithromycin: an analysis to inform future research and guidelinesAlex C Kong, Anthony D So
Health Affairs Scholar|May 21, 2024
Enabling product development partnerships to bring forward the next generation of health technologiesAnthony D So, Joshua Woo, Matthias Helble
BMJ (Clinical Research Ed.)|May 21, 2010
Tackling antibiotic resistanceAnthony D So, Neha Gupta, Otto Cars
BMJ (Clinical Research Ed.)|April 12, 2012
3Rs for innovating novel antibiotics: sharing resources, risks, and rewardsAnthony D So, Quentin Ruiz-Esparza, Neha Gupta, et al.
Infectious Diseases of Poverty|September 16, 2022
Ethical challenges in mass drug administration for reducing childhood mortality: a qualitative studyAhmed Alasmar, Alex C Kong, Anthony D So, et al.
Pageof 3